Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • PreScission Protease (PSP): Cleavage Workflow

    2026-09-28

    PreScission Protease (PSP): Practical Cleavage Guidance

    Removing an affinity tag is a distinct step from capturing and polishing a recombinant protein: cleavage must release the target while preserving its integrity and the conditions needed for downstream work. PreScission Protease (PSP), SKU K1101, is a recombinant fusion enzyme composed of human rhinovirus type 14 (HRV14) 3C protease fused to glutathione S-transferase (GST), produced in an Escherichia coli expression system. The APExBIO PreScission Protease (PSP) product information describes its recognition sequence and handling conditions; it does not specify a universal enzyme-to-substrate ratio or incubation duration.

    What This Product Solves

    PSP is a protein purification enzyme for fusion protein tag cleavage when the construct includes its recognition sequence, Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro. The enzyme cleaves between glutamine (Gln) and glycine (Gly). If that sequence is placed at a tag–target junction, cleavage can separate the tag from the target protein. Whether the released protein has its intended N-terminus depends on the construct design and junction residues, so confirm the sequence before starting.

    This specificity makes PSP useful for a planned cleavage step in a recombinant protein purification workflow, including GST fusion protein cleavage when the fusion construct has the required site. Its low temperature protease activity is suited to workflows that can be carried out at 4°C, a condition given in the product information. The enzyme should not be expected to remove unrelated tags, cut at arbitrary positions, or cleave a construct that lacks an accessible recognition site.

    Protocol Parameters

    Use the product-dossier conditions as the starting point where provided. The dossier does not give a cleavage buffer recipe, enzyme dose, substrate concentration, or reaction time; establish those for the specific construct with a small-scale test rather than assuming a universal setting.

    • Assay: Cleavage incubation. Value: 4°C. Applicability: PSP cleavage reactions. Rationale: The product information identifies this as the optimal low-temperature condition. This temperature is specified in the product dossier.
    • Assay: Long-term enzyme storage. Value: −80°C. Applicability: The supplied enzyme before use. Rationale: Storage at this temperature is specified to preserve activity. This value comes from the product dossier.
    • Assay: Aliquot storage. Value: −20°C for up to six months. Applicability: Aliquots prepared to limit repeated freeze–thaw cycles. Rationale: The dossier gives this storage option and duration for aliquots.
    • Assay: Enzyme dose and reaction duration. Value: Not specified in the supplied product information. Applicability: Each new target construct. Rationale: Determine a suitable dose and endpoint empirically using a small-scale cleavage test; this is a workflow recommendation, not a product-specified setting.

    Workflow Setup and QC Checklist

    Before cleavage

    • Check the target expression construct sequence for the complete recognition site and confirm that its position and orientation match the intended tag–target junction. Note any residues expected to remain on the released target.
    • Plan a small-scale test using a representative sample of the purified fusion protein. Compare an untreated sample with one or more PSP-treated samples; vary enzyme amount or incubation duration systematically while keeping other conditions consistent. These are workflow recommendations because the dossier does not provide a fixed ratio or time.
    • Use a cleavage buffer formulated for PSP, as indicated in the product information. Because no buffer composition is supplied here, consult the product documentation for the applicable formulation rather than substituting a buffer based only on its name. Keep the reaction at 4°C and use clean, appropriately chilled materials.
    • Thaw an aliquot with minimal handling, mix gently, and return it to the recommended storage condition promptly. Avoid repeated freeze–thaw cycles. The supplied material is described as a sterile, colorless liquid; do not infer enzyme activity from appearance alone.

    Assess cleavage and recovery

    Analyze matched pre- and post-reaction samples by SDS-PAGE as an initial check for a shift in the fusion-protein band and appearance of separated products. Use a tag-specific immunoblot or another suitable analytical method when band sizes overlap or the gel does not resolve the products. Include an untreated control to distinguish cleavage from degradation or sample loss. Confirm the identity and integrity of the recovered target with an assay appropriate to the protein and downstream application; a gel shift alone does not establish native function.

    After selecting conditions at small scale, apply them to the remaining sample and plan a cleanup step to separate target protein from released tag and protease. PSP itself is GST-fused, so a glutathione-resin step may be considered only if binding behavior and compatibility with the target workflow are confirmed. Check the final sample for residual protease or tag rather than assuming either has been fully removed. For a broader overview of the product’s tag-cleavage context, see PreScission Protease: Precision Cleavage for Fusion Protein Purification; this practical article focuses on setup and quality checks.

    Common Failure Modes and Fixes

    • No detectable cleavage: Recheck the construct sequence, site orientation, and accessibility in the folded fusion protein. Confirm that the enzyme was stored and handled as directed and that the reaction used an appropriate cleavage buffer. Test a controlled range of enzyme amounts or incubation durations at 4°C rather than making several changes at once.
    • Partial cleavage: Compare untreated and treated aliquots and extend the small-scale condition screen. Check whether the sample matrix or buffer carried over from purification is compatible with the cleavage buffer. Avoid assuming that a single incubation condition will work equally well for every target.
    • Unexpected bands or loss of intact target: Include a no-enzyme control and inspect the fusion protein before cleavage. If degradation is also present in the control, investigate sample handling and target stability separately from PSP activity. Confirm the expected junction and product sizes before interpreting the gel.
    • Target remains contaminated after cleavage: Cleavage separates components but does not, by itself, define a complete polishing strategy. Optimize the downstream separation for the target, tag, and GST-fused protease, then verify residual contaminants with an appropriate analytical method.

    Scope and Limitations

    The guidance here is based on the product information and general protein-purification practice, not on a matched published study or validation for a particular target. The supplied details establish the enzyme identity, recognition sequence, cleavage bond, preferred temperature, and storage conditions. They do not establish a universal buffer composition, reaction time, dose, yield, target compatibility, or downstream cleanup method.

    PSP is therefore appropriate to evaluate when a construct contains the specified site and the intended reaction can be tested at low temperature. It is not a general-purpose protease for arbitrary tag removal. Target folding, site accessibility, junction design, and buffer carryover can affect the outcome; verify cleavage and sample quality experimentally before scaling up or using the product in a sensitive downstream assay.

    Conclusion

    Use PSP for a construct with the compatible Gln–Gly cleavage site, conduct initial tests at 4°C, and verify both cleavage and cleanup with controls. Follow the stated storage guidance, while determining dose, reaction duration, and downstream separation empirically for each target.